Clover Health Investments, Corp. (CLOV)

From the record

Clover Health Investments, Corp.'s filings since 2020 show 5 warning events of 3 kinds: a notice about its exchange listing (8-K item 3.01, 3 times, the latest 2024-04-05); a warning not to rely on past financial statements (8-K item 4.02, the latest 2021-05-17); an auditor change (8-K item 4.01, the latest 2021-01-12) (its current reports).

From the record

Clover Health Investments, Corp.'s 7 filed years say what it did: revenue went from $462 million in fiscal 2019 to $1.9 billion in fiscal 2025, up 26.8% a year; it rose in 5 of 6 years; the deepest fall was 26% from fiscal 2021 to fiscal 2022; net income was positive in 0 of 7 of those years (its annual reports).

From the record

Return on equity: in the fiscal year ended 2025-12-31, Clover Health Investments, Corp. lost about 28 cents for every dollar of shareholders' money. Leverage: it owed about 43 cents per dollar of assets, and net share issuance: its share count grew 4.5% over the year (the filed statements).

From the record

Clover Health Investments, Corp.'s standing among 10 graded names in its industry family: revenue of $1.9 billion in fiscal 2025 ranks in the bottom 15% by size; a net margin of -4.4% ranks in the bottom 5%; revenue growth of 20.6% a year over the last 3 filed years ranks in the top 25% (its annual reports).

From the record

Clover Health Investments, Corp.'s leadership, from its insiders' filings and its current reports: the chief executive on the record is Toy, Andrew (Chief Executive Officer, as filed), filing under that title since 2023-01-04, 3.9 years (top 50% of its family); the 16 officers and directors filing in the last fifteen months have been on the record a median of 3.8 years (bottom 17%); 11 officer or director changes were reported on Form 8-K since 2023-11-13, against the 16 people in charge now (bottom 25%; fewer changes for each person reads higher) (the Form 4 record, its Form 8-K reports). Years count from a person's first filing in the SEC's data sets, which begin in 2006, so each is a floor.

From the record

Clover Health Investments, Corp.'s room to grow, from the newest filed statements (fiscal 2025): cash of $78 million against no long-term debt tagged leaves 14.5% of its assets as net cash, top 25% of its family; cash from operations less capital spending is -3.6% of revenue (bottom 5%) (its annual report).

From the record

Clover Health Investments, Corp.'s growth drivers, from the filed years to fiscal 2025: revenue grew 20.6% a year over the last three filed years against 26.8% over all 7, slowing (bottom 45% of its family); the newest year grew 40.4% (top 15%); capital spending grew -22.9% a year (bottom 5%) (its annual reports). Clover Health Investments, Corp. tags no split of its revenue by line in the annual report on file, so growth by line cannot be read here; research and capital spending are on the trend.

From the record

Clover Health Investments, Corp.'s newest year against its own record: revenue of $1.9 billion in fiscal 2025 came in 25.5% above the $1.5 billion its prior three years' pace pointed to (top 5% of its family); net income of $86 million against a prior three-year average of $199 million (top 25%); a net margin of -4.4% against -17% before (top 5%) (its annual reports).